Antegrin Therapeutics, LLC

Ballwin, MO 63021

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $219K
First Award Date 04/09/14
Most Recent Award Date 04/09/14

Key Personnel

Last Name Name Awards Contact

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 04/09/14 - 03/31/15

DESCRIPTION (provided by applicant): Idiopathic pulmonary fibrosis (IPF) is a deadly lung disease that affects an estimated 133,000 patients in the U.S. and more than 5 million worldwide. Median survival time after diagnosis is only 2-3 years, with a 5-year mortality rate exceeding 50%. IPF is the leading indication for lung transplant in most l...